top of page

Feasibility studies

We can help you lower your production biomolecule percentage, using our PlanTech technology.

Production outsourcing

We’ll provide an annual subscription of the proteins we developed for you. 

Facility set-up

We install the facility, give you proper training and provide support with certification.

Licensing

And when you’re ready, we’ll handle licensing so that you can use our platform at your site.

About us

Tiamat Sciences

Tiamat is on a mission to fuel the next biotechnology revolution. We are reinventing biomolecule production with our plant-based platform. 

Join the protein revolution

Our Executive Team

France-Emmanuelle is an experienced biochemist with a background in the pharmaceutical industry. She is deeply committed to making changes with a large-scale impact in the industry and it is her mission to create a shift towards sustainability and circularity.

France-Emmanuelle Adil
CEO & Chairman of the Board

Prathima is a seasoned executive with over 20 years of experience in the biotech industry with expertise in the development and manufacturing of biotech products leading to IND/BLA filings. Prathima has consistently driven critical initiatives and innovative strategies and has orchestrated operations to achieve sustainable growth and profitability.

Prathima Acharya, PhD
VP of Operations 

Montana is a dynamic leader with a proven track record in program and people management and over 10 years of industry experience in the biotech and healthcare industries. She drives impactful change by focusing on process improvement, streamlining operations, and increasing efficiency, all while maintaining exceptional employee engagement, 26% higher than industry standards.

Montana Wagner-Gillespie
Chief of Staff

Kelli comes to us with 15 years of business experience from corporate finance, investor relations, marketing, and strategy. Most recently she was the Chief of Staff for an early-stage start-up helping them complete a $21M oversubscribed Series A fundraise. Prior to that she was an Associate Director of Finance for Optum working on pricing and financial planning and analysis.

Kelli Reifschneider
Fractional CFO

Edric has 30 years of experience in healthcare as a VC venture partner, an SME in PE, an operating partner with C-Suite roles at portfolio companies along with experience running business units, key global functions, and leading key initiatives at McKinsey & Company. His focus is growth strategy and turnarounds and how to create integrated, downstream solutions from value propositions to capital planning to business development and infrastructure builds.

Edric Engert
Acting CBO

Plants, the new bioreactors 

Our plants are sustainable by design. They have an inherently low contamination risk and their rapid growth allows for fast product development iterations. 

Our Team

Asia brings 2 years of experience at Tiamat with N. benthamiana and spent 9 years as a Postdoctoral Researcher at UNC, Chapel Hill. She specializes vector design, protein expression and purification. 

Asia Polko, PhD
R&D Manager 
Process Development - Downstream

Hannah has 12 years of biotech industry at Medicago Inc. with N. benthamiana. Her expertise in research is directed toward commercial GMP manufacturing, process controls, and yield improvements of vaccine candidates using transient protein expression.

Hannah Reithinger
Process Development - Upstream

Chip brings over 20 years biotech industry experience (AgBiome, Bayer Crop, Synthon, Biolex) with extensive background and experience in molecular biology/genetic engineering, vectoring, designing & assembling constructs for plant transformations including N. benthamiana, and transient expression in plants.

Chip Peele
Vectoring 

Christian has 7 years biotech industry experience at Biogen with extensive background and experience in Analytical Development, Quality Control, and Tech Transfer for clinical and commercial biotech Drug Substance and Drug Products. He also brings industry experience in Assay Qualification, Assay Validation (ICH), cGMP, SOPs, and Regulatory experience.

Christian Beinpuo
Analytical Development / QC

Nathan brings to Tiamat 5 years of Plant Molecular Farming experience, 3 years of Greenhouse experience, and 2 years of Hydroponic experience.

Nathan Rogers
Plant Molecular Farming Specialist

Lisa brings to Tiamat 10 years of biotech industry experience at specifically working with N. benthamiana at Medicago Inc. She also has extensive background and experience in GMP manufacturing, process development, analytical testing, and tech transfer.

Lisa Seamans 
Process Development (Contract)

Kareyna is a Canadian native who obtained her bachelor's degree in Food Science at BYU-Idaho before moving to North Carolina. Kareyna provides Tiamat’s entire team with unsurpassed administrative support.

Kareyna Guevara
Executive Office Coordinator

Our Board

France-Emmanuelle is an experienced biochemist with a background in the pharmaceutical industry. She is deeply committed to making changes with a large-scale impact in the industry and it is her mission to create a shift towards sustainability and circularity.

France-Emmanuelle Adil
CEO & Chairman of the Board

Ryan is a serial entrepreneur & investor active in the novel food & biotech fields. Currently, he is CEO of Wild Earth (Healthy and Sustainable Plantbased Pet Food), co-founder at Sustainable Food Ventures & Tiamat's board member and advisor. Ryan's mission is to positively impact the lives of billions of people and animals through applied biotechnology.

Ryan Bethencourt
Advisor

bottom of page